Finnian Raymond McCausland, M.B.,B.Ch.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Renal Dialysis | 12 | 2023 | 1796 | 1.830 |
Why?
|
Kidney Failure, Chronic | 9 | 2024 | 2478 | 1.190 |
Why?
|
Hematinics | 3 | 2023 | 282 | 1.130 |
Why?
|
Dialysis Solutions | 3 | 2023 | 34 | 0.990 |
Why?
|
Hypotension | 4 | 2023 | 879 | 0.860 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2023 | 109 | 0.830 |
Why?
|
Angiotensin Receptor Antagonists | 10 | 2024 | 1039 | 0.720 |
Why?
|
Biphenyl Compounds | 9 | 2024 | 1007 | 0.640 |
Why?
|
Heart Failure | 12 | 2024 | 11701 | 0.560 |
Why?
|
Renal Insufficiency, Chronic | 5 | 2023 | 2254 | 0.540 |
Why?
|
Sodium | 2 | 2011 | 1589 | 0.530 |
Why?
|
Hypertension | 4 | 2023 | 8536 | 0.450 |
Why?
|
Tetrazoles | 6 | 2024 | 909 | 0.420 |
Why?
|
Marital Status | 1 | 2014 | 425 | 0.420 |
Why?
|
Blood Pressure | 4 | 2023 | 8479 | 0.400 |
Why?
|
Mannitol | 1 | 2012 | 177 | 0.390 |
Why?
|
Drug Combinations | 8 | 2024 | 2048 | 0.380 |
Why?
|
Kidney Diseases | 2 | 2012 | 2092 | 0.360 |
Why?
|
Diet, Sodium-Restricted | 1 | 2012 | 291 | 0.340 |
Why?
|
Cardiovascular Diseases | 5 | 2023 | 15520 | 0.330 |
Why?
|
Glomerulonephritis | 1 | 2011 | 333 | 0.330 |
Why?
|
Anemia | 1 | 2018 | 1504 | 0.320 |
Why?
|
Acute Kidney Injury | 2 | 2021 | 1923 | 0.300 |
Why?
|
Sodium, Dietary | 1 | 2012 | 425 | 0.300 |
Why?
|
Glomerular Filtration Rate | 3 | 2024 | 2182 | 0.280 |
Why?
|
Lyme Disease | 1 | 2011 | 631 | 0.240 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3821 | 0.240 |
Why?
|
Kidney Transplantation | 2 | 2023 | 4242 | 0.210 |
Why?
|
Weight Gain | 1 | 2011 | 2349 | 0.190 |
Why?
|
Urea | 1 | 2023 | 442 | 0.190 |
Why?
|
Hyperkalemia | 1 | 2023 | 233 | 0.190 |
Why?
|
Arteriovenous Shunt, Surgical | 3 | 2008 | 290 | 0.190 |
Why?
|
Hypocalcemia | 1 | 2021 | 200 | 0.170 |
Why?
|
Glucosides | 1 | 2024 | 512 | 0.160 |
Why?
|
Erythropoietin | 1 | 2023 | 719 | 0.160 |
Why?
|
Benzhydryl Compounds | 1 | 2024 | 917 | 0.140 |
Why?
|
Kidney | 5 | 2024 | 7033 | 0.140 |
Why?
|
Hemodiafiltration | 1 | 2016 | 18 | 0.140 |
Why?
|
Male | 20 | 2024 | 360693 | 0.140 |
Why?
|
Stroke Volume | 7 | 2024 | 5521 | 0.140 |
Why?
|
Atrial Appendage | 1 | 2019 | 283 | 0.130 |
Why?
|
Smoking | 1 | 2012 | 9055 | 0.130 |
Why?
|
Aged | 14 | 2024 | 169288 | 0.120 |
Why?
|
Middle Aged | 15 | 2024 | 220853 | 0.120 |
Why?
|
Female | 19 | 2024 | 392544 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 4 | 2022 | 1504 | 0.120 |
Why?
|
Insurance Claim Review | 1 | 2019 | 741 | 0.120 |
Why?
|
Urine | 1 | 2016 | 362 | 0.120 |
Why?
|
Uric Acid | 1 | 2020 | 807 | 0.120 |
Why?
|
Osmolar Concentration | 1 | 2015 | 659 | 0.110 |
Why?
|
Prospective Studies | 6 | 2023 | 54435 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5842 | 0.110 |
Why?
|
Humans | 32 | 2024 | 761208 | 0.110 |
Why?
|
Double-Blind Method | 2 | 2018 | 12341 | 0.110 |
Why?
|
Hypertonic Solutions | 1 | 2012 | 82 | 0.100 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11476 | 0.100 |
Why?
|
Diuretics, Osmotic | 1 | 2012 | 33 | 0.100 |
Why?
|
Treatment Outcome | 9 | 2024 | 64681 | 0.100 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2011 | 65 | 0.090 |
Why?
|
Metabolic Clearance Rate | 1 | 2011 | 362 | 0.090 |
Why?
|
Cause of Death | 1 | 2021 | 3688 | 0.090 |
Why?
|
Delayed Graft Function | 1 | 2011 | 53 | 0.090 |
Why?
|
Hemostasis, Surgical | 1 | 2011 | 126 | 0.090 |
Why?
|
Blood Volume | 1 | 2012 | 547 | 0.090 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 362 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 12159 | 0.090 |
Why?
|
Hematuria | 1 | 2011 | 232 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10218 | 0.090 |
Why?
|
Antigen-Antibody Complex | 1 | 2011 | 509 | 0.080 |
Why?
|
Stroke | 2 | 2023 | 9721 | 0.080 |
Why?
|
Hyponatremia | 1 | 2011 | 280 | 0.080 |
Why?
|
Adult | 7 | 2023 | 221119 | 0.080 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2015 | 926 | 0.070 |
Why?
|
Potassium | 1 | 2012 | 1309 | 0.070 |
Why?
|
Postoperative Hemorrhage | 1 | 2011 | 416 | 0.070 |
Why?
|
Morbidity | 1 | 2012 | 1751 | 0.070 |
Why?
|
Dietary Proteins | 1 | 2012 | 951 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3418 | 0.060 |
Why?
|
Patient Readmission | 1 | 2019 | 3265 | 0.060 |
Why?
|
Diabetic Nephropathies | 1 | 2012 | 973 | 0.060 |
Why?
|
Time Factors | 3 | 2018 | 39957 | 0.060 |
Why?
|
Energy Intake | 1 | 2012 | 2133 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2019 | 3627 | 0.060 |
Why?
|
Nutritional Status | 1 | 2012 | 1597 | 0.050 |
Why?
|
Blood Vessel Prosthesis | 1 | 2008 | 951 | 0.050 |
Why?
|
Ramipril | 1 | 2023 | 102 | 0.050 |
Why?
|
Vascular Surgical Procedures | 2 | 2008 | 1489 | 0.050 |
Why?
|
Risk Assessment | 2 | 2016 | 24021 | 0.050 |
Why?
|
Linear Models | 1 | 2012 | 5869 | 0.050 |
Why?
|
Hemodynamics | 1 | 2012 | 4165 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2019 | 5114 | 0.050 |
Why?
|
Erythropoiesis | 1 | 2023 | 683 | 0.040 |
Why?
|
Survival Analysis | 1 | 2012 | 10088 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 281 | 0.040 |
Why?
|
Cohort Studies | 2 | 2012 | 41496 | 0.040 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 3899 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12052 | 0.040 |
Why?
|
Hospitalization | 2 | 2022 | 10707 | 0.040 |
Why?
|
Risk Factors | 3 | 2023 | 74239 | 0.040 |
Why?
|
Renin-Angiotensin System | 1 | 2022 | 735 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12474 | 0.040 |
Why?
|
Hemoglobins | 1 | 2023 | 1525 | 0.040 |
Why?
|
Aftercare | 1 | 2022 | 913 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2008 | 3608 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39126 | 0.030 |
Why?
|
Prevalence | 1 | 2012 | 15721 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22140 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7407 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2023 | 3702 | 0.030 |
Why?
|
Prognosis | 1 | 2011 | 29687 | 0.020 |
Why?
|
Patient Discharge | 1 | 2022 | 3441 | 0.020 |
Why?
|
Population Surveillance | 1 | 2019 | 2598 | 0.020 |
Why?
|
United States | 2 | 2019 | 72339 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 21365 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2019 | 5295 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12728 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8003 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2008 | 2112 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 80674 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58952 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2008 | 15637 | 0.000 |
Why?
|